abstract |
The invention relates to (-)-5-(3-Chlorophenyl)-.alpha.-(4-chlorophenyl)-.alpha.-(1-methyl-1H-imidazol-5-yl)tetrazolo-[1,5-a]quinazoline-7-methanamine and its pharmaceutically acceptable acid addition salts, and the use of such compounds in medicine especially for the treatment of cancer. |